drugset / Trial / NCT05469646
A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 1819479 in healthy male Japanese subjects receiving single rising doses (SRD) in order to provide the basis for a clinical development of BI 1819479 in Japan.
Timeline
- Start
- 2022-08-03
- Primary completion
- 2022-12-20
- Completion
- 2022-12-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1819479 | Unknown | — | — |
Indications
No indication recorded.